Medical/Pharmaceuticals
CBC Group Announces the Appointment of Roger Perlmutter as Science Partner
SHANGHAI, March 15, 2021 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment firm, is pleased to announce that Roger M. Perlmutter, M.D., Ph.D., currently non-Executive Chairman, Merck Research Laboratories, joins CBC as Science Partner and a member of its Scientific Advisory Bo...
2021-03-15 22:00
3440
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs
VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...
2021-03-15 20:00
3679
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...
2021-03-15 19:00
3486
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...
2021-03-15 19:00
5464
Antengene Included in the Shenzhen-Hong Kong Stock Connect
SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...
2021-03-15 09:40
5032
Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea
SHANGHAI and SEOUL, South Korea, March 15, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolo...
2021-03-15 08:00
4186
Agiomix Receives the First ISO 15189 Accreditation for Next Generation Sequencing in the Region
DUBAI, UAE, March 15, 2021 /PRNewswire/ -- Agiomix has received the ISO
15189:2012 Accreditation from the Emirates International Accreditation Centre
for Next Generation Sequencing clinical assays.
2021-03-15 07:50
2712
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
MELBOURNE, Australia, March 15, 2021 /PRNewswire/ -- SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisati...
2021-03-15 07:08
2010
Thinklabs Announces Medical Device Single Audit Program (MDSAP) Certification and TGA Approval in Australia
Thinklabs is opening business to Australian territories, inclusive of hospitals, private practices, and medical facilities. CANBERRA, Australia, March 9, 2021 /PRNewswire/ -- Thinklabs, manufacturer of Thinklabs One, the smallest, most powerful electronic stethoscope in the world, today ann...
2021-03-12 23:06
4930
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately$1 billion, which includes buyer's assumption of certain liabilities and seller's retention o...
2021-03-12 22:00
9057
Harbour BioMed Announces Dosing of First Patient in Tanfanercept Phase III Clinical Trial
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI and SUZHOU, China, March 12, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142) today announced the dosing of the first patient in the Phase III clinical trial of its new global investigational tumor necrosis factor (TNF) receptor-1 f...
2021-03-12 09:00
6682
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
- 100% protection against severe disease - Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19 - Efficacy against variants confirmed in U.K. and South Africa GAITHERSBURG, Md., March 12, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnolog...
2021-03-12 05:04
4634
A large randomized clinical trial shows significant reduction in urinary tract infections
STOCKHOLM, March 12, 2021 /PRNewswire/ -- A recently published, randomized, controlled multicenter study inIndia shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard cat...
2021-03-12 01:30
2442
Elekta's Board of Directors proposes additional dividend of SEK 0.90 per share
STOCKHOLM, March 12, 2021 /PRNewswire/ -- The Board of Directors of Elekta (EKTA-B.ST) proposes an extra dividend for the fiscal year 2019/20. According to the communication in connection with the ordinary dividend, the Board announced that Elekta may propose an additional dividend so that the t...
2021-03-12 01:12
4813
Global Medical Imaging Informatics Market Accelerated by Cloud and AI to Enable Deployment Options and Support Decision-making
Modern informatics solutions will drive revenue in developed markets as hospitals try to improve productivity and efficiency within imaging departments, finds Frost & Sullivan SANTA CLARA, Calif., March 12, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the emergence of new t...
2021-03-12 00:34
2929
U.S. and EU Kidney Groups Align for Global Innovation Consortium
WASHINGTON, March 11, 2021 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), the largest U.S. kidney patient organization, today joined the European Kidney Patients' Federation (EKPF) and the European Kidney Health Alliance (EKHA) in a new collaboration designed to expand the ro...
2021-03-11 21:58
2293
Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines
SHANGHAI, March 11, 2021 /PRNewswire/ -- Delonix Bioworks Ltd. (Delonix), a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a$14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF) and IDG ...
2021-03-11 21:21
1961
Gore REDUCE Clinical Study Five-Year Results Demonstrate That PFO Closure With The GORE® CARDIOFORM Septal Occluder Provides Safe Long-Term Reduction Of Recurrent Stroke
- Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone.*,¹ - Long-term results highlight GORE® CARDIOFORM Septal Occluder can be trusted for patient safety ...
2021-03-11 20:00
3696
Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021
* Published economic modelling shows estimated reduction in hospital episodes and potential financial savings from remote patient monitoring technology. * Baxter supports World Kidney Day Steering Committee in declaring 2021 the year of "Living Well with Kidney Disease". SINGAPORE, March 11, 2...
2021-03-11 16:38
3487
Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients
SUZHOU, China, March 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced today top-line results from its investigator-initiated Brazil trial evaluating the efficacy of Proxalut...
2021-03-11 14:54
5177
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 316 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 300 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
7552
